Corcept Therapeutics Incorporated (CORT) Social Stream
Corcept Therapeutics Inc (CORT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CORT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $35 | $16 | $24.75 | $23.8 | 3.99% |
| 2022-01-26 | 4 | $35 | $16 | $25.5 | $23.8 | 7.14% |
| 2022-01-28 | 5 | $35 | $16 | $26.4 | $23.8 | 10.92% |
| 2022-02-02 | 6 | $35 | $16 | $27 | $23.8 | 13.45% |
| 2022-04-01 | 6 | $35 | $16 | $27.166 | $23.8 | 14.14% |
The Trend in the Analyst Price Target
Over the past 23 months, CORT's average price target has gone up $11.67.
CORT reports an average of 23.23% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-01 | 3 | 35 | 16 | 25.25 | 20.77 | 21.57% |
| 2021-08-07 | 3 | 35 | 16 | 25.25 | 21.83 | 15.67% |
| 2021-08-14 | 3 | 35 | 16 | 25.25 | 20.68 | 22.1% |
| 2021-09-19 | 3 | 35 | 16 | 25.25 | 20.51 | 23.11% |
| 2022-01-28 | 5 | 35 | 16 | 26.40 | 17.61 | 49.91% |
CORT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.83 | 4 | 0 | 1 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
CORT's average broker recommendation rating improved by 0 over the prior 59 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CORT as an investment opportunity.
- In terms of how Corcept Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -315.61% of that group.
- CORT has a greater upside potential (average analyst target price relative to current price) than 32.31% of Pharmaceutical Products stocks.
- In terms of how Corcept Therapeutics Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 132.29% of that group.
- CORT has a greater average analyst price target than 147.95% of stocks in the mid market cap category.
Stocks similar to Corcept Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CMRX, CLVS, and CERE.
Is CORT a Buy, Hold or Sell? See the POWR Ratings now!